Enalaprilat Injection Market

This product is colorless and clear liquid. It is not suitable for rapid blood pressure reduction in hypertensive emergencies where oral antihypertensive drugs are not suitable.COVID-19 has erupted in the world, and these drugs are in short supply.

Enalaprilat Injection Market contains market size and forecasts of Enalaprilat Injection in global, including the following market information:

Global Enalaprilat Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Enalaprilat Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Enalaprilat Injection companies in 2021 (%)

The global Enalaprilat Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

1.25mg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Enalaprilat Injection include Hikma, Pfizer, SteriMax, Sandoz and Changzhou Oharmaceutical Factory, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Enalaprilat Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Enalaprilat Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Enalaprilat Injection Market Segment Percentages, by Type, 2021 (%)

• 1.25mg/ml
• 2.5mg/2ml

Global Enalaprilat Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Enalaprilat Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Enalaprilat Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Enalaprilat Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Enalaprilat Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Enalaprilat Injection revenues share in global market, 2021 (%)
• Key companies Enalaprilat Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Enalaprilat Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Hikma
• Pfizer
• SteriMax
• Sandoz
• Changzhou Oharmaceutical Factory